Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy against Tuberculosis

Developing new effective treatment strategies to overcome the rise in multi-drug resistant tuberculosis cases (MDR-TB) represents a global challenge. A host-directed therapy (HDT), acting on the host immune response rather than Mtb directly, could address these resistance issues. We developed an HDT...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahlool, Ahmad Z., Fattah, Sarinj, O’Sullivan, Andrew, Cavanagh, Brenton, MacLoughlin, Ronan, Keane, Joseph, O’Sullivan, Mary P., Cryan, Sally-Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415714/
https://www.ncbi.nlm.nih.gov/pubmed/36015371
http://dx.doi.org/10.3390/pharmaceutics14081745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415714/
https://www.ncbi.nlm.nih.gov/pubmed/36015371
http://dx.doi.org/10.3390/pharmaceutics14081745

Ejemplares similares